Vaccination Worldwide: Strategies, Distribution and Challenges

Chirag Samal, Kasia Jakimowicz, Krishnendu Dasgupta, Aniket Vashishtha, Olga Isaza De Francisco, Arunakiry Natarajan, Haris Nazir, Alluri Siddhartha Varma, Tejal Dahake, Amitesh Anand Pandey, Ishaan Singh, John Sangyeob Kim, Mehrab Singh Gill, Saurish Srivastava, Orna Mukhopadhyay, Parth Patwa, Qamil Mirza, Sualeha Irshad, Sheshank Shankar, Rohan Iyer, Rohan Sukumaran, Ashley Mehra, Anshuman Sharma, Abhishek Singh, Maurizio Arseni, T V Sethuraman, Saras Agrawal, Vivek Sharma, Ramesh RaskararXiv 2021 · DOI · arXiv

Abstract: The Coronavirus 2019 (Covid-19) pandemic caused by the SARS-CoV-2 virus represents an unprecedented crisis for our planet. It is a bane of the über connected world that we live in that this virus has affected almost all countries and caused mortality and economic upheaval at a scale whose effects are going to be felt for generations to come. While we can all be buoyed at the pace at which vaccines have been developed and brought to market, there are still challenges ahead for all countries to get their populations vaccinated equitably and effectively. This paper provides an overview of ongoing immunization efforts in various countries. In this early draft, we have identified a few key factors that we use to review different countries' current COVID-19 immunization strategies and their strengths and draw conclusions so that policymakers worldwide can learn from them. Our paper focuses on processes related to vaccine approval, allocation and prioritization, distribution strategies, population to vaccine ratio, vaccination governance, accessibility and use of digital solutions, and government policies. The statistics and numbers are dated as per the draft date [June 24th, 2021].

Introduction

While the scientific community developed vaccines at an unprecedented pace, the transition from production to administration—the "last-mile" problem—presented a massive logistical and ethical challenge. This paper provides a comprehensive cross-sectional analysis of the global COVID-19 immunization effort as it stood in mid-2021. By examining the administration strategies of over 20 countries, we offer a comparative framework for understanding how different nations tackled the most significant public health challenge of the century.

Global distribution of vaccine administration percentages as of June 24, 2021.

Methodology

To evaluate global progress, we employed a comparative review methodology based on seven key factors: prioritization schemes, approved vaccines, administration and distribution logistics, population-to-vaccine ratios, vaccination governance, accessibility through digital solutions, and broader government policies. Data was synthesized from official government records, the PathCheck Foundation’s Vaccination Dashboard, and temporal data from Our World in Data.

Key Insights and Strategies

Digital Infrastructure as a Force Multiplier

Countries that invested in robust digital platforms saw significant benefits in tracking and efficiency. India’s Co-WIN platform allowed for real-time tracking of every dose from manufacturer to recipient. Similarly, Turkey’s Vaccine Tracking System (ATS) utilized QR codes to monitor temperature and location throughout the cold chain, ensuring vaccine integrity and reducing waste.

Logistical Diversity and Prioritization

Distribution models varied based on national infrastructure. Canada utilized military support for a decentralized provincial model, whereas Germany employed a hybrid approach, using 27 designated central points followed by state-level distribution. Prioritization also reflected national needs; while most focused on healthcare workers and the elderly, China prioritized transport and social workers early on to maintain essential services.

Results and Global Disparities

As of June 24, 2021, the scale of the global effort was immense but highly uneven. China led the world in absolute doses, surpassing 1.1 billion administered. However, relative progress showed extreme disparity. Canada achieved a population-to-vaccine ratio of approximately 88.99 per 100 people, whereas Egypt stood at roughly 4.04 per 100.

Cumulative COVID-19 vaccine doses administered over time across selected nations, highlighting the growth trajectories of major campaigns.

Conclusion and Limitations

This study serves as a vital historical and technical record of a global race against time. However, it is limited by the temporal sensitivity of pandemic data and inconsistencies in international reporting standards regarding "fully vaccinated" status. Future research should focus on the long-term social and economic effects of these strategies as nations transition toward a post-pandemic normalcy.

Summary updated

Abstract

The Coronavirus 2019 (Covid-19) pandemic caused by the SARS-CoV-2 virus represents an unprecedented crisis for our planet. It is a bane of the über connected world that we live in that this virus has affected almost all countries and caused mortality and economic upheaval at a scale whose effects are going to be felt for generations to come. While we can all be buoyed at the pace at which vaccines have been developed and brought to market, there are still challenges ahead for all countries to get their populations vaccinated equitably and effectively. This paper provides an overview of ongoing immunization efforts in various countries. In this early draft, we have identified a few key factors that we use to review different countries' current COVID-19 immunization strategies and their strengths and draw conclusions so that policymakers worldwide can learn from them. Our paper focuses on processes related to vaccine approval, allocation and prioritization, distribution strategies, population to vaccine ratio, vaccination governance, accessibility and use of digital solutions, and government policies. The statistics and numbers are dated as per the draft date [June 24th, 2021].
BibTeX
@misc{samal2021vaccination,
  author = {Chirag Samal and Kasia Jakimowicz and Krishnendu Dasgupta and Aniket Vashishtha and Olga Isaza De Francisco and Arunakiry Natarajan and Haris Nazir and Alluri Siddhartha Varma and Tejal Dahake and Amitesh Anand Pandey and Ishaan Singh and John Sangyeob Kim and Mehrab Singh Gill and Saurish Srivastava and Orna Mukhopadhyay and Parth Patwa and Qamil Mirza and Sualeha Irshad and Sheshank Shankar and Rohan Iyer and Rohan Sukumaran and Ashley Mehra and Anshuman Sharma and Abhishek Singh and Maurizio Arseni and T V Sethuraman and Saras Agrawal and Vivek Sharma and Ramesh Raskar},
  title = {{Vaccination Worldwide: Strategies, Distribution and Challenges}},
  year = {2021},
  eprint = {2107.14139},
  archivePrefix = {arXiv},
  url = {https://arxiv.org/abs/2107.14139},
}
Figure